FibroBiologics (FBLG) Net Shares Issued and Repurchased (2023 - 2025)

FibroBiologics (FBLG) has reported Net Shares Issued and Repurchased for 3 consecutive years, with $1.4 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Net Shares Issued and Repurchased rose 83.33% year-over-year to $1.4 million; the trailing twelve-month figure through Dec 2025 stood at $1.4 million (up 83.33% YoY), and the FY2025 full-year result was $1.4 million, up 34.72% from the prior year.
• Net Shares Issued and Repurchased improved to $1.4 million in Q4 2025 per FBLG's latest filing, from $831000.0 in the prior quarter.
• Across five years, Net Shares Issued and Repurchased topped out at $3.7 million in Q4 2023 and bottomed at $6875.0 in Q2 2024.
• Historically, Net Shares Issued and Repurchased has averaged $1.1 million across 3 years, with a median of $794869.5 in 2024.
• The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased tumbled 79.44% in 2024, then soared 283.17% in 2025.
• Over 3 years, Net Shares Issued and Repurchased stood at $3.7 million in 2023, then sank by 79.44% to $758739.0 in 2024, then surged by 83.33% to $1.4 million in 2025.
• According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $1.4 million, $831000.0, and $758739.0 for Q4 2025, Q1 2025, and Q4 2024 respectively.